Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00778154 · ClinicalTrials.gov registry record
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate
A clinical trial of Postmenopausal Osteoporosis, sponsored by Warner Chilcott.
- Completed
- Registry status
- 105
- Enrollment target
- 8
- Study locations
NCT00778154 is a study of Postmenopausal Osteoporosis that has completed, run by Warner Chilcott. The registered enrollment target is 105 participants, below the 577-participant average among 12 other Postmenopausal Osteoporosis trials with a reported enrollment target (82% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT00778154, a study of Postmenopausal Osteoporosis, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
- 8
- Study locations
Study Summary
Patients who have received the appropriate number of years of alendronate or risedronate therapy will be recruited. Each patient will have received baseline BMD measurements performed at the spine and the hip by DXA. Each patient will receive tetracycline to label the bone and then have a transiliac bone biopsy. One year later teh bone label and biopsy procedure will be repeated.
Conditions Studied
Study Locations (8)
Georgia
- Warner Chilcott Research Facility - Decatur
- Warner Chilcott Research Facility - Gainesville
California
- Warner Chilcott Research Facility - Palm Desert
Colorado
- Warner Chilcott Research Facility - Lakewood
Nebraska
- Warner Chilcott Research Facility - Omaha
Ohio
- Warner Chilcott Research Facility - Cincinnati
Pennsylvania
- Warner Chilcott Research Facility - Wyomissing
Quebec
- Warner Chilcott Research Facility - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00778154
The ClinicalTrials.gov registry entry for NCT00778154 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 577-participant average among 12 other Postmenopausal Osteoporosis trials with a reported enrollment target (82% lower). The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postmenopausal Osteoporosis appearing as the primary indexed condition, and to 0 interventions.
NCT00778154 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Georgia, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT00778154 about?
NCT00778154 is a clinical study titled "Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate". Patients who have received the appropriate number of years of alendronate or risedronate therapy will be recruited. Each patient will have received baseline BMD measurements performed at the spine and the hip by DXA. Each patient will receive tetracycline to label the bone and then have a transiliac...
What is the current status of trial NCT00778154?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2004-01. Estimated completion is 2006-12.
What conditions does trial NCT00778154 study?
This clinical trial studies the following conditions: Postmenopausal Osteoporosis.
Who is sponsoring clinical trial NCT00778154?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00778154 being conducted?
This trial has 8 study locations across California, Colorado, Georgia, Nebraska, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postmenopausal Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dried Plums and Bone Health in Postmenopausal Women
ACTIVE NOT RECRUITING · NA
-
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
ACTIVE NOT RECRUITING · Phase 2
-
Anabolic Therapy in Postmenopausal Osteoporosis
ACTIVE NOT RECRUITING · Phase 4
-
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
COMPLETED · Phase 3
-
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
COMPLETED · Phase 4
-
A Study of Monthly Risedronate for Osteoporosis
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.